UNICA IRIS Institutional Research Information System

DONISI, CLELIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.194
NA - Nord America 1.335
AS - Asia 845
SA - Sud America 153
AF - Africa 23
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 21.555
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 18.735
US - Stati Uniti d'America 1.279
CN - Cina 322
SG - Singapore 309
SE - Svezia 142
BR - Brasile 126
DE - Germania 76
VN - Vietnam 50
GB - Regno Unito 46
IN - India 44
FI - Finlandia 40
FR - Francia 40
NL - Olanda 33
CA - Canada 32
KR - Corea 31
HK - Hong Kong 27
PL - Polonia 19
MX - Messico 18
AT - Austria 13
ES - Italia 10
IE - Irlanda 10
EC - Ecuador 9
ZA - Sudafrica 9
BE - Belgio 8
IR - Iran 7
AE - Emirati Arabi Uniti 5
AR - Argentina 5
IQ - Iraq 5
JP - Giappone 5
PK - Pakistan 5
TR - Turchia 5
VE - Venezuela 5
AU - Australia 4
LT - Lituania 4
PH - Filippine 4
PY - Paraguay 4
TH - Thailandia 4
BD - Bangladesh 3
CZ - Repubblica Ceca 3
GR - Grecia 3
ID - Indonesia 3
KG - Kirghizistan 3
PT - Portogallo 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
AL - Albania 2
DZ - Algeria 2
IL - Israele 2
LU - Lussemburgo 2
SC - Seychelles 2
TN - Tunisia 2
UZ - Uzbekistan 2
AZ - Azerbaigian 1
BH - Bahrain 1
BJ - Benin 1
CH - Svizzera 1
CL - Cile 1
CO - Colombia 1
CY - Cipro 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
HR - Croazia 1
JM - Giamaica 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 21.555
Salva come PNG Salva come JPEG
Città #
Cagliari 17.554
Uta 987
Dallas 238
Ashburn 235
Singapore 150
Boardman 94
Nyköping 74
Beijing 67
Chandler 66
Los Angeles 53
New York 50
Fairfield 42
Hefei 40
Shanghai 33
Rome 31
Seoul 30
Santa Clara 29
Munich 27
Florence 25
The Dalles 25
Hong Kong 24
Amsterdam 22
Helsinki 22
Seattle 22
Boston 19
Houston 19
Ho Chi Minh City 18
Redondo Beach 18
Nuremberg 16
Guangzhou 15
Frankfurt am Main 14
Pune 14
Wilmington 14
Montreal 13
San Diego 13
Warsaw 13
Woodbridge 13
Cambridge 12
Chennai 11
São Paulo 11
Shenzhen 10
Toronto 10
Chicago 9
Denver 9
Düsseldorf 9
Lappeenranta 9
Buffalo 8
Dublin 8
London 8
Mexico City 8
Milan 8
Turku 8
Hanoi 7
Johannesburg 7
Stockholm 7
Paris 6
Vienna 6
Bexley 5
Forlì 5
Menlo Park 5
Poplar 5
Rio de Janeiro 5
Roubaix 5
San Francisco 5
Sassari 5
Selargius 5
Zhengzhou 5
Brussels 4
Dong Ket 4
Haiphong 4
La Maddalena 4
Manila 4
Naples 4
Olbia 4
Orem 4
Phoenix 4
Portsmouth 4
Wroclaw 4
Wuhan 4
Ankara 3
Atlanta 3
Bishkek 3
Biên Hòa 3
Brooklyn 3
Buenos Aires 3
Campinas 3
Charlotte 3
Clifton 3
Council Bluffs 3
Dubai 3
Guayaquil 3
Hangzhou 3
Islington 3
Joinville 3
Manchester 3
Naaldwijk 3
Osasco 3
Peristeri 3
Piscataway 3
Quito 3
Totale 20.471
Salva come PNG Salva come JPEG
Nome #
Molecular-biology-driven treatment for metastatic colorectal cancer 2.711
New therapeutic targets in pancreatic cancer 1.589
Immunotherapy and Cancer: The Multi-Omics Perspective 1.553
Hepatocellular carcinoma and microbiota: Implications for clinical management and treatment 1.304
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.179
CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors 997
Neoadjuvant chemo-radiotherapy response in patients affected by mismatch repair deficient (dMMR) locally advanced rectal cancer 938
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 900
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 890
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 740
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 710
Uncovering key targets of success for immunotherapy in pancreatic cancer 676
Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer 669
Circulating tumour DNA in gastrointestinal cancer in clinical practice: Just a dream or maybe not? 664
Next-Generation Sequencing Whole-Genome Analysis for Targeted Treatment Approach of Metastatic Bartholin Gland Adenocarcinoma: An Emblematic Case Report and Review of the Literature 662
BRCA-mutant pancreatic ductal adenocarcinoma 579
Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy 558
Immune Checkpoint Inhibitors in the Treatment of HCC 547
Prediction of Response to Anti-Angiogenic Treatment for Advanced Colorectal Cancer Patients: From Biological Factors to Functional Imaging 524
Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment 510
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 507
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 432
Emerging treatment evolutions and integrated molecular characteristics of biliary tract cancers 412
Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score 247
Mismatch repair proteins (MMR) expression as predictive factor in locally advanced rectal cancer 171
Thyroid dysfunction and immune checkpoint inhibitors: Effect on survival in elderly patients 150
Overall survival and progression-free survival in metastatic colorectal cancer patients with concomitant RAS and BRAF mutations: a single center experience 144
Early taxane exposure and neurotoxicity in breast cancer patients 143
Early-onset colorectal cancer patients exhibit a distinct molecular fingerprint: insights from a large-scale NGS study of 1209 patients 128
Exercise Prescription in Cardio-Oncology 66
Clinical characteristics and outcomes in patients with early-onset locally advanced rectal cancer 64
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 64
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 56
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 49
The correlation between L1CAM expression and outcomes in patients with metastatic colorectal cancer treated with first-line chemotherapy 47
The impact of surgical resection in early onset colorectal cancer patients with liver limited disease 46
Clinical and molecular features of early-onset metastatic pancreatic cancer and their impact on therapeutic sequences: A multicenter study 42
Totale 21.668
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.156
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.156
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021693 0 0 0 0 0 205 58 116 47 116 76 75
2021/20221.168 69 63 4 29 60 100 61 89 77 116 228 272
2022/20233.703 325 526 339 242 270 296 202 311 297 407 314 174
2023/20243.429 159 117 113 184 273 553 549 245 243 239 368 386
2024/20259.999 2.859 3.319 854 923 453 645 423 58 99 119 76 171
2025/20261.643 297 243 400 345 300 58 0 0 0 0 0 0
Totale 21.668